Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency

NEXT STORY
Zentalis Pharmaceuticals Announces Proposed Public Offering of Common Stock
PREV STORY
Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Checkmate Pharmaceuticals Presents New Clinical Trial Translational Data with Vidutolimod at the 2021 American Association for Cancer (AACR) Annual Meeting

author_avatar
NASDAQ Market News

Automated blood Tube Labeler & Specimen Transport Box Market – Global Future | Emerging Growth Prospects by 2026

NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Automated blood Tube Labeler is a ...

author_avatar
NASDAQ Market News

Why Online/Virtual Fitness Market Booms Globally, to Register 33.1% CAGR by 2027?

author_avatar
NASDAQ Market News